Researchers used a trio of transcription factors to transform pancreatic duct cells in vivo into β-like cells that secrete insulin and improve diabetes symptoms.

The new classification system could help improve personalized medicine approaches to the disease.

Pancreatic cells engineered to produce insulin did not immediately provoke an immune response.

Scientists build a biosensor skin patch for noninvasive glucose monitoring. 

A needle-free alternative to the finger-prick test would be a godsend for many sufferers of diabetes, but the industry has yet to clear the technological hurdles.

A small clinical trial demonstrates that peptide immunotherapy can halt the progression of early-stage type 1 diabetes.

The diabetic volunteer continued to produce insulin one year after she received a transplant of abdominal islet cells.

Three therapeutic doses administered during early life disturb the animals’ microbiomes and lead to enduring changes in the immune systems of non-obese diabetic mice, researchers report.